“I’ve had Seeking Alpha Premium for 3 months and I am very impressed with the product. Their stock screeners and quant ratings and analyst recommendations beat the S&P on a consistent basis. I told a friend about and he bought the service and is also extremely satisfied. I highly recomme...
Everyone says Seeking Alpha is a great source of information, but from what I can see is it is simply an opinion base. Why would I want to pay &30+ a month for an opinion? I see lots of people writing articles on something they profess they don’t even own. Some are cautionary tal...
Be the first to know about market moving news and analysis on the stocks you follow. The Seeking Alpha app gives you access to our: • Real time, concise news c…
Have been a subscriber to Seeking Alpha (SA) & CEF/ETF Income Lab for almost one year. I was not new to investing, but was new to CEFs when I arrived and have learned a lot about CEFs and income investing since I joined. Have found Stanford Chemist (SC) to be extremely thorough, ...
TRAFFIC RANK FOR SEEKINGALPHA.COM Date Range 1 week 1 month 3 months This Year Last Year All time TODAY'S RATING #1,836 TRAFFIC RANK - AVERAGE PER MONTH Date Range All Time This Year Last Year BEST MONTH August AVERAGE PER DAY Of THE WEEK Date Range All Time This Year Last Year...
Join the community. Try Seeking Alpha for free by creating an account »Create Free AccountCreate a free account to read the full article Gain access to the world’s leading investment community. Already registered? Sign in Create Free Account By creating an account using any of the options ...
http://seekingalpha.com/article/448841-lilly-will-reward-patient-investors Sign in / Join Now. Lilly Will Reward Patient Investors. Value, dividend investing, research analyst, long-term horizon. Eli Lilly (NYSE: LLY. This challenge has been known for years and the company has been preparing....
http://seekingalpha.com/article/448841-lilly-will-reward-patient-investors Sign in / Join Now. Lilly Will Reward Patient Investors. Value, dividend investing, research analyst, long-term horizon. Eli Lilly (NYSE: LLY. This challenge has been known for years and the company has been preparing....
By discussing the neural systems traditionally tied to navigation and reward at their intersection, we aim to offer an integrated framework for understanding navigation to reward as a fundamental feature of many cognitive processes. This is a preview of subscription content, access via your institution...
Tilly looks on disapprovingly, but there's a method to Rayner's madness. The 20-word limit is his strategy for getting the crew to tell him what's most important to them so he can break them down for analysis. Tilly says that misses the broader point of forming connections. Yeah, yeah...